The Global Health Financing Architecture and the Millennium Development Goals

Author(s):  
Marco Schäferhoff ◽  
Christina Schrade ◽  
Matthew T. Schneider
2010 ◽  
Vol 29 (6) ◽  
pp. 345-345
Author(s):  
Suzanne Rait

THIS YEAR WAS THE CENTENNIAL OF FLORENCE Nightingale’s death and in commemoration, was designated as the International Year of the Nurse (IYNurse) by The Honor Society of Nursing, Sigma Theta Tau in the U.S., The Nightingale Initiative for Global Health in Canada, and the Florence Nightingale Museum in England. 2010 IYNurse is “a collaborative, grassroots global initiative honoring nurses’ voices, values, and wisdom—to act as catalysts for achieving a healthy world.” In this “celebration of commitment,” we honor Florence Nightingale as the founder of modern nursing and for the legacy she left us and we recognize the contributions of nurses today, all over the world. At the 2010 IYNurse website, you can read stories contributed by nurses that illustrate progress made in each of the eight UN Millennium Development Goals. Another section of the website contains tributes to nurses and to the nursing experience. A video of the Commemorative Global Service Celebrating Nursing that took place this past April at the Washington National Cathedral is also available for viewing. I hope you will visit this website and possibly make a contribution to nursing’s story.


2019 ◽  
Vol 74 (3) ◽  
pp. 463-471
Author(s):  
Giorgi Buzaladze ◽  
Andrew Defor

Global Health Diplomacy has been instrumental in achieving many of the world’s global health goals, such as the Millennium Development Goals. The new Sustainable Development Goals are ambitious, and all tools need to be employed to make sure they are achieved by the 2030 deadline. This paper reviews the successes and failures of the health-related Millennium Development Goals. It uses the lessons learned to put forward a sustainable approach toward the Sustainable Development Goals, and explores the role of Global Health Diplomacy in advancing the health goals.


2012 ◽  
Vol 18 (4) ◽  
Author(s):  
James Class

Over the past decades, global health has moved from discrete disease campaigns to major developmental strategies. However, medication affordability remains an important, unsolved challenge for industry and the global community. This effort requires coordinated actions by multiple stakeholders. Industry can play a specific role through responsible, differentiated pricing of medicines. Public policies should incentivize such pricing policies rather than discouraging them by external reference pricing or parallel trade. Providing opportunities for industry to invest in emerging markets sustainably, patients will benefit from greater access and support attainment of the UN Millennium Development Goals.


Sign in / Sign up

Export Citation Format

Share Document